HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UC Berkeley Study Raises Concerns About Metals In Lipstick Beyond Lead

This article was originally published in The Rose Sheet

Executive Summary

UC Berkeley researchers urge FDA to conduct further research on metals in lip products – beyond just lead – following their study the likelihood for “excessive” chromium exposure and “potential overexposure” to three other metals linked to adverse health effects.

You may also be interested in...



Pending Calif. Consumer Products Reg Inconsistent, Unfair – Trade Groups

The Personal Care Products Council and the Consumer Healthcare Products Association fault the latest and likely last draft of California’s Safer Consumer Products regs for its lack of a weight-of-evidence approach to decision making and inadequate trade-secret protections, among other shortcomings.

Pending Calif. Consumer Products Reg Inconsistent, Unfair – Trade Groups

The Personal Care Products Council and the Consumer Healthcare Products Association fault the latest and likely last draft of California’s Safer Consumer Products regs for its lack of a weight-of-evidence approach to decision making and inadequate trade-secret protections, among other shortcomings.

Problems Remain In Calif. Consumer Products Reg, Slated For October

The Personal Care Products Council faults the latest and likely last draft of California’s Safer Consumer Products regs for its lack of a weight-of-evidence approach to decision making and inadequate trade-secret protections, among other shortcomings.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel